Chocolate and cocoa flavanols have been associated with improvements in a range of health complaints dating from ancient times, and has established cardiovascular benefits. Less is known about the effects of chocolate on neurocognition and behaviour. The aim of this study was to investigate whether chocolate intake was associated with cognitive function, with adjustment for cardiovascular, lifestyle and dietary factors. Cross-sectional analyses were undertaken on 968 community-dwelling participants, aged 23e98 years, from the Maine-Syracuse Longitudinal Study (MSLS). Habitual chocolate intake was related to cognitive performance, measured with an extensive battery of neuropsychological tests. More frequent chocolate consumption was significantly associated with better performance on the Global Composite score, Visual-Spatial Memory and Organization, Working Memory, Scanning and Tracking, Abstract Reasoning, and the Mini-Mental State Examination. With the exception of Working Memory, these relations were not attenuated with statistical control for cardiovascular, lifestyle and dietary factors. Prospective analyses revealed no association between cognitive function and chocolate intake measured up to 18 years later. Further intervention trials and longitudinal studies are needed to explore relations between chocolate, cocoa flavanols and cognition, and the underlying causal mechanisms.
Introduction
Chocolate consumption is widespread throughout the world. In 2009, 7.2 million tons of chocolate was consumed worldwide (Statista, 2015) . Commonly associated with pleasure and enjoyment, chocolate is a frequently 'craved' food (Macht & Dettmer, 2006; Macht & Mueller, 2007; Parker, Parker, & Brotchie, 2006) , possibly due to its rich natural complexity (Wilson, 2010) . The sweet taste, high carbohydrate and fat content and highly palatable orosensory qualities, obtained from its specific constituents, may all contribute to its appeal as a 'comfort' food. Few other natural products have been purported to have as many medicinal benefits as chocolate. From very early times to the present day, chocolate has been used to reduce fever, treat childhood diarrhoea, promote strength before sexual conquests, decrease 'female complaints', increase breast-milk production, encourage sleep and to clean teeth (Wilson, 2010) . More recent scientific interest has been directed at the cardiovascular (Heiss, Keen, & Kelm, 2010; Hooper et al., 2012) and neurocognitive benefits (Scholey & Owen, 2013; Sokolov, Pavlova, Klosterhalfen, & Enck, 2013) derived from chocolate and cocoa consumption. The cardiovascular benefits have been well established from dietary intervention trials showing improvements in insulin sensitivity (Grassi, Lippi, Necozione, Desideri, & Ferri, 2005) , blood pressure (Grassi et al., 2005) , endothelial function (Engler et al., 2004; Heiss et al., 2007) and cerebral blood flow (Sorond, Lipsitz, Hollenberg, & Fisher, 2008) . In contrast to the evidenced-based benefits from cocoa and chocolate consumption on cardiovascular health, the precise impact of chocolate on human cognitive function is less clear.
Ageing is usually accompanied by declines in multiple domains of cognitive function, including memory and processing speed. In the absence of effective treatments for neurodegenerative disorders, nutritional practises targeted at preventing or slowing cognitive decline may contribute significantly towards optimising cognitive functioning across the adult life-span (Bryan, 2004; Solfrizzi, Panza, & Capurso, 2003; Van Dyk & Sano, 2007; Crichton, Bryan, Murphy, & Buckley, 2010; Crichton et al., 2012; Haider et al., 2011) . The ability of flavonoid-rich foods to improve cognitive function has been demonstrated in both epidemiological studies (Letenneur, Proust-Lima, Le Gouge, Dartigues, & Barberger-Gateau, 2007; Nurk et al., 2009 ) and clinical trials (Macready et al., 2009) .
Chocolate and cocoa products are a rich source of flavonoids. Flavanoids, naturally occurring polyphenolic compounds present in plant-based foods, represent up to 20% of the compounds present in cocoa beans (Sokolov et al., 2013) . Flavanols, and in particular epicatechin, are a subgroup of flavonoids, and are the most common cocoa flavonoids (Sokolov et al., 2013) . High levels of flavanols are also found in tea, red wine, and fruits such as grapes and apples (Gu et al., 2004) . In addition to cocoa flavonols, other psychoactive components of chocolate include the methylxanthines, caffeine and theobromine, both of which have been associated with improving alertness and cognitive function (Smit, Gaffan, & Rogers, 2004; Mitchell et al., 2011) . The amount of cocoa in chocolate ranges from approximately 7e15% in milk chocolate, to 30e70% in dark chocolate. One hundred grams of dark chocolate contains approximately 100 mg of flavanols, while 100 g of unsweetened cocoa powder without meythlxanthines can contain up to 250 mg of flavanols (Bhagwat, Haytowitz, Holden) .
Two randomized trials have demonstrated improvements in cognitive function following a single dose of chocolate or cocoa flavanols (Scholey et al., 2010; Field, Williams, & Butler, 2011) . Benefits to information processing speed and working memory were observed in these studies within hours of consuming cocoa flavanols or dark chocolate. Less research has examined the effects from the longer-term consumption of chocolate or cocoa. One recent randomized controlled trial, the Cocoa, Cognition, and Aging (CoCoA) Study, has provided evidence that daily consumption of cocoa flavanols can improve cognitive function in healthy, elderly individuals (Mastroiacovo et al., 2015) . Consistent with the immediate effect studies (Field et al., 2011; Scholey et al., 2010) , improvements in processing speed and attentional tasks were seen following 8-weeks of consuming an intermediate to high daily dose of cocoa flavanols (Mastroiacovo et al., 2015) .
In contrast to the aforementioned research, some studies using a more chronic administration of chocolate or cocoa flavanols, ranging from 5 days to 6 weeks, have failed to find any positive effects on cognition (Crews, Harrison, & Wright, 2008; Camfield et al., 2012; Francis, Head, Morris, & Macdonald, 2006) . It is possible that the variability in the flavanol content in chocolate, which may vary according to the bean variety, origin and manufacturing processes, may contribute to the mixed outcomes observed in studies to date on the effects of cocoa flavanols on cognition (Sokolov et al., 2013) .
We have not identified any cohort studies that have examined associations between longer-term habitual chocolate consumption over a number of years, with cognitive functioning measures. The existing evidence remains limited and inconclusive. Using data collected from participants in the Maine-Syracuse Longitudinal Study (MSLS), the aim of the present study was to determine whether habitual chocolate intake is associated with improved cognitive function, with consideration given to cardiovascular, lifestyle and dietary factors.
Materials and methods

Participants
The MSLS was a community-based study of cardiovascular risk factors and cognitive functioning in adults (Dore, Elias, Robbins Robbins, Elias, Elias, & Budge, 2005) . The MSLS consists of five cohorts defined by time of entry into the study (1975e2000, see Appendix 1). At initial recruitment, participants were living independently in Syracuse, New York State. Participants in the present study were those returning for the sixth study wave (2001e2006), as dietary intake measures and extensive data on risk factors for CVD were first obtained at wave 6. From a sample of 1049 individuals, participants were excluded for the following reasons: missing dietary or cognitive data (n ¼ 38), acute stroke (n ¼ 28), probable dementia (n ¼ 8), undertaking dialysis treatment (n ¼ 5), inability to read English (n ¼ 1), and prior alcohol abuse (n ¼ 1), leaving 968 participants. Dementia cases were excluded as we were interested in examining relationships between diet and cognitive performance in those without severe cognitive impairment because poorer cognitive performance in such individuals is a major risk factor for dementia (Elias et al., 2000; Tierney, Moineddin, & McDowell, 2010 ) and Alzheimer's Disease (Tierney, Yao, Kiss, & McDowell, 2005) . The clinical diagnosis of dementia was determined by committee using the National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria, MSLS cognition data, diagnostic records and medical interview data (McKhann et al., 1984) . Stroke was defined as a focal neurological deficit of acute onset persisting for more than 24 h, and was based on self-report or medical records.
This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures were approved by the University of Maine Institutional Review Board. Written informed consent was obtained from all subjects.
Procedure and assessment
Dietary Intake Dietary intake was also assessed using the Nutrition and Health Questionnaire . Participants were required to stipulate how frequently they consume a list of foods, including meat, fish, eggs, breads, cereals, rice and pasta, fruit, vegetables, dairy foods, chocolate, nuts, other snack-type foods and beverages, including tea, coffee, water, fruit juice and alcohol. Participants were required to stipulate how frequently they consumed each food, from six response options: never, seldom, once/week, 2e4 times/week, 5e6 times/week, and once or more per day. Chocolate was not differentiated according to type, ie. milk, dark or white chocolate.
In order to estimate mean intake of the major food groups and total energy intake, the median score within each response option was used to estimate total intake per week; for example, 2e3 times per week was estimated at 2.5. The mean number of times each food was consumed on a weekly and then daily basis was calculated for all foods in the questionnaire. Because portion sizes were not stipulated to participants, these totals are an estimate of the number of times each food was consumed on a daily basis. Individual foods were categorised into five major food groups e grains, fruits, vegetables, protein foods, and dairy foods e based on the USDA Food Guide Pyramid (United States Department of Agriculture, 2011). Intake of individual foods and beverages within each food group were summed to give an estimate of total intake for each group. An estimation of total energy intake was calculated by adding intake of all food groups, and was used to control for energy intake in subsequent analyses.
Cognitive Function Cognitive function was assessed using the MSLS neuropsychological test battery, which has been used in numerous health and cognition studies (Dore et al., 2008; Elias, Robbibs et al., 2009 Robbins et al., 2005; ). The following composite scores have been previously derived using factor analysis from 20 individual tests designed to measure a wide range of cognitive domains: visual-spatial memory and organization, scanning and tracking, verbal episodic memory, and working memory. The WAIS Similarities Test (Lezak, Howieson, & Loring, 2004) , a measure of abstract reasoning, loaded on all composite scores (factors) and was thus employed separately. A global cognition composite score was derived by averaging the zscores for all individual tests and then re-standardizing these scores to obtain a z-score with a mean of zero and SD of 1.00. In addition, the Mini-Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975) , a global measure of mental status widely used in the literature, was included in the MSLS battery. The derivation of these composites has been described previously (Elias et al., 2006) and they have been repeatedly utilized in MSLS studies. All cognitive performance measures are expressed in the same unit of measurement (SD units), i.e. z-scores, with higher scores indicating better performance.
Demographics and Physical Health Assessment Demographic, socioeconomic and lifestyle characteristics were obtained from the Nutrition and Health Questionnaire . Data obtained included smoking history, marital status and medical history. Physical activity was measured with the Nurses' Health Study Activity Questionnaire, a validated measure of time spent engaging in various physical activities (Wolf et al., 1994) . The Center for Epidemiological Studies Depression Scale (CES-D) (Radloff, 1977) was used to assess depressive symptoms. Education level was obtained through self-report (mean ¼ 14.7 ± 2.7 years, range 4e20 years).
Standard assay methods were employed (Elias et al., 2006 ) to obtain fasting plasma glucose (mg/dL), total cholesterol (TC, mg/ dL), low-density lipoprotein cholesterol (LDL, mg/dL), high-density lipoprotein cholesterol (HDL, mg/dL), triglycerides (mg/dL) and Creactive protein (CRP, mg/L), following an overnight fast. Body weight was measured with participants wearing light clothing to the nearest 0.1 kg, and height was measured with a vertical ruler to the nearest 0.1 cm. Body mass index (BMI) was calculated as weight in kilograms divided by height in metres squared. Waist circumference (in centimetres) was taken over light clothing, using a nonextendable measuring tape, at the level of the iliac crest. Automated blood pressure measures (GE DINAMAP 100DPC-120XEN, GE Healthcare) were taken in the right arm five times each in recumbent, standing and sitting position after a supine rest for 15 min, and averaged for systolic and diastolic blood pressure. Obesity was defined as having BMI of at least 30 kg/m 2 .
Statistical analyses
Participant demographics, health and dietary variables, and cognitive scores were compared according to chocolate consumption (never/rarely vs. at least once/week). Independent samples ttests were used for continuous variables and Chi-square for categorical variables.
For the primary analyse, chocolate intake was further classified into three intake groups based on self-reported frequency of consumption: less than once per week, once per week, and more than once per week. Multivariate analysis of variance (MANOVA) (a stepdown protection procedure) (van der Laan, Dudoit, & Pollard, 2004) was used to examine relationships between chocolate intake and cognitive performance (Visual-Spatial Memory and Organization, Scanning and Tracking, Verbal Episodic Memory, Working Memory, Similarities, MMSE). All cognitive outcomes were entered into the analyses simultaneously as dependent variables except for the Global Composite score, as the Global Composite is co-dependent on all the measures other than the MMSE. Multivariate ANOVA was used to examine relationships between chocolate intake and the Global Composite. In addition to MANOVA, the Bonferroni procedure was used to protect against multiple comparisons.
Potential confounding factors were identified on the basis of two criteria: (1) had to be theoretically relevant (Jaccard & Jacoby, 2010) and, (2) had to show a statistically significant association (p < 0.05) with both chocolate intake and the Global Composite. Three covariate sets were used:
(1) Covariate set 1: age, sex.
(2) Covariate set 2: age, sex, education, total cholesterol, glucose, LDL-cholesterol, hypertension, estimated energy intake (total daily intake of all food groups as previously described). (3) Covariate set 3: covariate sets 1 and 2, plus dietary intake of alcohol, meats, vegetables, and dairy foods.
The other risk factors measured as potential covariates did not correlate significantly with chocolate consumption (predictor) or an outcome measure and therefore were not included in the statistical models.
All statistical analyses were performed with PASW for Windows ® version 21.0 software (formerly SPSS Statistics Inc. Chicago, IL, USA); p < 0.05 was considered statistically significant. Table 1 shows the demographic and health-related variables, cognitive scores, and dietary intake for MSLS participants (n ¼ 968), according to chocolate consumption (those who consume chocolate never or rarely, compared with at least once per week). Effect sizes are shown for those variables where there were significant differences between groups (p < 0.05). Women ate chocolate more frequently than men. Compared to those who never or rarely ate chocolate, those who ate chocolate on a weekly basis, had higher total and LDL-cholesterol, but lower glucose levels. Hypertension and type 2 diabetes were lower in regular chocolate consumers than in non-consumers. From a dietary perspective, those who ate chocolate also consumed more energy overall, and more daily serves of meat, vegetables and dairy foods, but significantly less alcohol. All cognitive scores were significantly higher in those who consumed chocolate at least once per week, than in those who never/rarely consumed chocolate.
Results
Participant characteristics and chocolate consumption
Chocolate Consumption and Cognitive Performance in the MSLS.
The multivariate tests performed as protection against multiple contrasts for multiple outcome variables were statistically significant for all three models (covariate set 1: F [Wilks' lambda] ¼ 2.93, p < 0.001; covariate set 2: F ¼ 2.43, p ¼ 0.004; covariate set 3: F ¼ 2.21, p ¼ 0.009). Therefore we report the results of the univariate analyses for each cognitive outcome. Table 2 shows the adjusted mean z-scores (and SE) for each cognitive outcome across increasing categories of chocolate intake (all three models). P-values are adjusted via the Bonferroni procedure. Chocolate intake was significantly and positively associated with the Global Composite, Visual-Spatial Memory and Organization, Working Memory, Scanning and Tracking, the Similarities test (abstract reasoning), and the MMSE (covariate set 1, all p < 0.05).
With full adjustment for demographic variables, cardiovascular risk factors, and a number of dietary variables including total energy intake, significant positive associations remained between chocolate intake and the Global Composite, Visual-Spatial Memory and Organization, Scanning and Tracking, Similarities and the MMSE (covariate set 3, all p < 0.05). There were no associations observed between chocolate intake and Verbal Memory.
Secondary analyses
In a secondary analysis, we asked whether cognitive performance predicted chocolate consumption rather than the other way round. This analysis was conducted on a sample of participants (n ¼ 333) who had completed a cognitive assessment in waves 1e4 of the MSLS, but also completed the dietary questionnaire at wave 6, a mean of 18.0 years later (Crichton, Elias, Davey, Alkerwi, & Dore, 2014) . Cognition was assessed using the Wechsler Adult Intelligence Scale (WAIS) (Wechsler, 1955) , consisting of a total WAIS score, Verbal subscale score and Performance subscale score. There were no significant associations between chocolate intake and the total WAIS (p ¼ 0.90), Verbal subscale (p ¼ 0.70) or Performance subscale (p ¼ 0.80) (all adjusted for age, sex and education).
Although income did not fit our criteria for inclusion as a covariate (did not correlate significantly with chocolate intake), it may influence food choices and dietary patterns. We therefore added income to the basic model, and the results remain unchanged.
Discussion
Chocolate intake was positively associated with cognitive performance, across a range of cognitive domains in this dementiafree, community-dwelling population. The associations between more frequent weekly chocolate consumption and cognitive performance remained significant after adjustment for a number of cardiovascular risk factors, including total and LDL-cholesterol, glucose levels, and hypertension. Associations were not attenuated with the addition of dietary variables (alcohol, meats, vegetables, and dairy foods), indicating that chocolate may be associated with cognition irrespective of other dietary habits.
A number of studies provide support for the role of cocoa flavanols in cognition (Field et al., 2011; Mastroiacovo et al., 2015; Scholey et al., 2010) . In a placebo-controlled, double blind study, (Scholey et al. 2010 ) compared cognitive effects following the consumption of drinks containing either 520 mg of cocoa flavanols, 994 mg of cocoa flavanols, or a matched control drink in 30 healthy young adults. Mood and cognitive performance were assessed over 60 min post-drink. Performance on a serial subtraction task significantly improved following consumption of both flavanolcontaining drinks, compared to the control. The 994 mg cocoa flavanol beverage significantly increased the speed on visual information processing responses, while increases in self-reported 'mental fatigue' were significantly attenuated by the consumption of the 520 mg beverage. (Field et al. 2011 ) similarly examined the acute effects of cocoa flavanols on cognitive function (reaction time, visual spatial working memory), visual contrast sensitivity, and motion sensitivity, in a cross-over study in 30 healthy young adults. Participants consumed dark chocolate containing 720 mg cocoa flavanols, and a matched quantity of white chocolate. The dark chocolate improved visual spatial working memory, reaction time on some aspects of the test, contrast sensitivity, and reduced the time to detect motion direction. The authors attributed these findings to increased cerebral blood flow caused by the cocoa flavanols. Findings from these two studies demonstrated that improved cognitive effects may be observed at 90e120 min post-flavanol intake (Field et al., 2011; Scholey et al., 2010) .
Findings from the recent CoCoA Study support this research (Mastroiacovo et al., 2015) . In this trial, the effects of daily consumption (for 8 weeks) of a drink containing low (48 mg), intermediate (520 mg), or high (993 mg) levels of cocoa flavanols on cognitive performance in 90 elderly, cognitively intact participants were examined. The intermediate and high flavanol groups both showed improvements in processing speed and attentional tasks (measured by the Trail Making Test), whilst improvements in verbal fluency (Verbal Fluency Test) were greatest for the high flavanol group. General cognition scores, as measured by the MMSE, were not significantly different between groups post-treatment. Further, improvements in insulin resistance, blood pressure, and lipid profile were detected in the high and intermediate flavanol groups, compared with the low flavanol group. Importantly, benefits were noted at multiple intake amounts. Some improvement was observed in the low flavanol group for verbal fluency, however to a lesser degree than in the other two treatment groups. The authors attributed this to the meythlxanthines (50 mg caffeine, 400 mg theobromine) in the low flavanol drink (Mastroiacovo et al., 2015) .
Other research has supported the action of the methylxanthines in chocolate, caffeine and theobromine, in relation to cognitive function. Coffee is consumed by millions of individuals from all over the world, possibly in part, due to its caffeine content. It is the best known psychoactive stimulant acting to improve short-term alertness and arousal (Mitchell et al., 2011; Yoshimura, 2005) . Longer-term, population based studies have provided evidence that long-term caffeine intake may offer some protection against cognitive decline (Panza et al., 2015) .
Studies by (Smit et al. 2004 ) have provided evidence for the beneficial effects of the methylxanthines contained in chocolate. They measured the effects on cognitive performance and mood from the consumption of the equivalent amount of cocoa powder and methylxanthines (caffeine and theobromine combination) found in a 50 g bar of dark chocolate. Identical improvements on energetic arousal and cognitive function were found for cocoa powder and the methylxanthines versus a placebo. In chocolate, both 'milk' and 'dark' chocolate methylxanthine doses improved cognitive function compared with 'white chocolate'. In subsequent work, Smit and Blackburn (2005) also demonstrated that the methylxanthines in amounts found in 50 g of chocolate may well contribute to our 'liking' of chocolate.
Other studies have supported the findings of (Smit et al. 2004 ). (Mitchell et al. 2011 ) compared the effects of caffeine (120 mg), theobromine (700 mg), the combination of both, or a placebo, on mood and cognitive performance (psychomotor speed). Theobromine alone decreased calmness, caffeine alone increased alertness and contentedness, while the combination of both had similar effects as caffeine alone on mood, although neither improved psychomotor speed. However, the levels of caffeine and theobromine administered in this study were higher than what is present in chocolate products. A number of recent reviews have explored the central actions of cocoa flavanols in relation to cognition (Sokolov et al., 2013) and mood (Smith, 2013) . Excellent reviews by (Sokolov et al. 2013 ) and Williams and Spencer (2012) discuss how the actions of cocoa flavanols and flavonoids, respectively, impact upon neurocognition and behaviour. To summarize, flavanols have multiple effects on brain function, but their neuropsychological actions are likely to occur in two ways: 1) via direct interactions with cellular and molecular signalling cascades in brain regions involved with learning and memory, and 2) via increasing central and peripheral blood flow and promoting angiogenesis (Sokolov et al., 2013; Williams & Spencer, 2012) .
Cardiovascular health is closely linked to cognitive health (Waldstein and Elias, 2014) . Further, the relation between dietary habits and the human brain is complex and involves bi-directional communication. Intellectual status early in life may certainly effect good or poor food choices (Crichton et al., 2014 ). However, we were able to asses for any relation between cognitive performance measured at waves 1e4 of the MSLS, with chocolate intake at wave 6, and found no prospective associations. Performance on the WAIS, which combines both verbal and performance abilities, did not predict chocolate intake controlling for age, sex, and education.
Income may be another factor that potentially influences the relation between chocolate consumption and cognitive function. It may be speculated that higher income individuals may purchase and consume more chocolate, and in particular dark chocolate, which has a higher flavanol content. However, sensitivity analyses with income added to the basic model, did not change the findings. We also note that those who consumed chocolate more frequently drank significantly less alcohol. Another plausible explanation may be that alcohol actually has a deleterious effect on cognitive function, explaining the results observed. However, additional analyses revealed no association between alcohol intake and the Global Composite, Visual-Spatial Memory and Organization, Scanning and Tracking, or the Similarities test (all p > 0.2, all covariate set 3). Alcohol intake was, in fact, significantly, positively associated with Verbal Memory, Working Memory and the MMSE (unstandardized B ¼ 0.001, p < 0.05 for all, covariate set 3) (data not shown).
Limitations
Some limitations of the present study should be acknowledged. Chocolate intake was self-reported, and therefore subject to inherent reporting error. The dietary questionnaire used did not require the respondent to differentiate between dark, milk or white chocolate. Most clinical trials have used dark chocolate as the source of cocoa flavanols. In 2012, the distribution share of chocolate in the United States by favourite chocolate type was 57% milk chocolate, 35% dark chocolate, and 8% white chocolate (Statista, 2015) . We can therefore make the assumption that the majority of chocolate consumed in this sample was dark or milk, both containing cocoa flavanols to varying degrees. With the exception of the secondary analysis, the study was cross-sectional as longitudinal data following wave 6 were not available. This precludes any conclusions regarding a causal relationship between chocolate intake and cognition from being drawn. Future longitudinal studies in this area will be of value.
Strengths
Our study demonstrated positive associations between habitual chocolate consumption and cognitive performance. We were able to statistically control for a number of cardiovascular, lifestyle and dietary variables that may impact upon a chocolateecognition relationship. Despite the dietary intervention trials which have typically examined the effects from either a single dose or daily doses over periods up to several months, there have not been any large cross-sectional studies identified that have specifically examined chocolate intake in relation to cognitive performance. Further, we were able, with a prospective design, to examine the relation between early cognitive functioning (at waves 1 to 4) and chocolate consumption (at wave 6), and found no association.
Conclusion
It is evident that nutrients in foods exert differential effects on the brain. As has been repeatedly demonstrated, isolating these nutrients and foods enables the formation of dietary interventions to optimise neuropsychological health. Adopting dietary patterns to delay or slow the onset of cognitive decline is an appropriate avenue, given the limited treatments available for dementia. The present findings support recent clinical trials suggesting that regular intake of cocoa flavanols may have a beneficial effect on cognitive function, and possibly protect against normal age-related cognitive decline. Longer-term clinical trials will shed further insight into this association between chocolate, rich in cocoa flavanols, and neuropsychological health, and the mechanisms linking them. It will be important in future studies to investigate optimal quantities and duration of consumption to produce short or longertem effects while taking into account overall dietary patterns, where foods high in flavonoids are consumed in combination. Enhancing chocolate and cocoa consumption whilst ensuring appropriate caloric intake will be an important consideration to optimise the benefits obtained from these foods.
